Development, Optimization and Evaluation of Ozenoxacin Nanoemulgel for the Treatment of Impetigo
Background- Impetigo, a highly infectious superficial epidermal infection caused by Streptococci and Staphylococcus aureus, is commonly treated with topical antibacterial agents. Ozenoxacin is the drug of choice, a potent quinolone antibiotic, recently approved by (USFDA) in December 2017 with reported antibacterial ac...